bleomycetin has been researched along with epirubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Han, X; Lang, J; Leng, J; Xiang, Y | 1 |
| Cai, BL; Fu, SM; Guan, SM; Shen, LL; Wu, JZ; Xu, XF; Zhang, J | 1 |
2 other study(ies) available for bleomycetin and epirubicin
| Article | Year |
|---|---|
Vaginal adenosarcoma arising from refractory endometriosis: a case report.
Topics: Adenofibroma; Adenosarcoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Endometriosis; Epirubicin; Etoposide; Female; Gestrinone; Humans; Hysterectomy; Ifosfamide; Membrane Proteins; Ovariectomy; Salpingectomy; Treatment Outcome; Vaginal Neoplasms; Vincristine | 2010 |
Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Blotting, Western; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorescent Antibody Technique, Indirect; Fluorouracil; Humans; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Salivary Gland Neoplasms | 2011 |